China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- Vice-premier urges all-out efforts to search for people missing after Gansu mountain torrents
- Zhejiang transforms once-polluted land into industrial park
- China activates Level-IV emergency response for flood control in 5 provincial-level regions
- Flash floods leave 15 dead, 28 missing in Gansu
- Foshan succeeds in curbing the spread of chikungunya
- Death toll in mountain torrents in NW China's Gansu rises to 13
